A Review of the Integrative Treatment Approach Using the Intravenous Alpha-Lipoic Acid/Low Dose Naltrexone (ALA/N) Protocol for Cancer and a Description of the Long-Term Survival of a Woman with Hepatocellular Carcinoma
Describes integrative treatment for hepatocellular carcinoma using IV alpha-lipoic acid and low dose naltrexone, leading to long-term survival and symptom improvement.





